Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Predicting tumor response to cytotoxic therapy

Hospital Practice

|December 1, 1980

Summary

This summary is machine-generated.

Achieving tumor regression through therapy significantly improves patient survival and quality of life. This review covers methods for predicting tumor response and chemotherapy strategies based on dose-response relationships and tumor kinetics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas.

Cancer·1999

Same author

The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen: a phase I-II study of paclitaxel, cisplatin, and vinorelbine.

Cancer·1999

Same author

Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.

Cancer·1998

Same author

Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: a Mid-Atlantic Oncology Program Study.

Annals of oncology : official journal of the European Society for Medical Oncology·1997

Same author

Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.

Cancer·1996

Same author

Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis.

Cancer·1996

Area of Science:

Oncology
Pharmacology
Clinical Medicine

Background:

Tumor regression is a key indicator of successful cancer therapy, correlating with improved patient survival and quality of life.
Predicting and understanding tumor response are crucial for optimizing treatment strategies.

Purpose of the Study:

To outline criteria for assessing tumor regression.
To provide clinical guidelines for predicting patient response to cancer therapy.
To review chemotherapy tactics, focusing on dose-response relationships and the kinetics of tumor response.

Main Methods:

Review of established criteria for determining tumor regression.
Analysis of clinical guidelines for predicting therapeutic response.
Examination of cancer chemotherapy strategies, including dose-response dynamics and response kinetics.

Related Experiment Videos

Main Results:

Established criteria for evaluating tumor regression are presented.
Clinical guidelines for predicting tumor response are detailed.
An overview of chemotherapy tactics, emphasizing dose-response and kinetics, is provided.

Conclusions:

Accurate prediction of tumor response is essential for enhancing patient survival and quality of life.
Understanding dose-response relationships and tumor kinetics is fundamental to effective cancer chemotherapy.
This review synthesizes current knowledge to guide clinical practice in cancer therapy and response assessment.